ArticleExperimental and therapeutic medicine2022

Rosiglitazone ameliorates acute hepatic injury via activating the Nrf2 signaling pathway and inhibiting activation of the NLRP3 inflammasome.

Ling Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.